Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma
NCT01754350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2021-06-02
Summary
Increased glucose metabolism is characteristic for solid tumors. Thereby, glucose is important for the generation of ATP, supply of anabolic substrates and defense against reactive oxygen species in tumor cells. In preclinical models, restricting glucose availability using a ketogenic diet, calorie-restriction or transient fasting inhibits tumor growth.
Therefore, the purpose of the study is to evaluate whether a calorie-restricted, ketogenic diet and transient fasting can enhance the efficacy of reirradiation in patients with recurrent glioblastoma.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
calorie-restricted ketogenic diet and transient fasting
On day 1-3 and day 7-9, restriction of carbohydrates to \< 60 g and of calories to 21-23 kcal/kg per day, on day 4-6 fasting. On day 1-3 and 7-9, restriction of carbohydrates can be supported by the use of drinks provided by "Tavarlin".
- DIETARY_SUPPLEMENT
-
standard nutrition
nutrition as recommended by the german society for nutrition, 30 kcal/kg per day
Sponsors & Collaborators
-
Tavarlin
collaborator INDUSTRY -
Johann Wolfgang Goethe University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2019-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
NCT03451799 ·Status: COMPLETED ·Phase: PHASE1
-
Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
NCT01865162 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy
NCT02149459 ·Status: UNKNOWN ·Phase: PHASE1
-
Glioma Modified Atkins-based Diet in Patients With Glioblastoma
NCT02286167 ·Status: COMPLETED ·Phase: NA
-
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
NCT02709226 ·Status: COMPLETED ·Phase: PHASE1
-
Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
NCT02939378 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
NCT01535911 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress
NCT01092247 ·Status: UNKNOWN ·Phase: NA
-
Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
NCT02780024 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00014300 ·Status: COMPLETED ·Phase: PHASE2
-
Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
NCT03055208 ·Status: SUSPENDED ·Phase: NA
-
Bioavailability of Disulfiram and Metformin in Glioblastomas
NCT03151772 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
NCT04019002 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
NCT04691960 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
NCT01339052 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Radiation Therapy for Glioblastoma Multiforme
NCT01466686 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
NCT00253448 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00053183 ·Status: COMPLETED ·Phase: PHASE1
-
INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
NCT02104882 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT04406610 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
NCT04977375 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
NCT01464177 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Repeat Resection in Recurrent Glioblastoma
NCT04838782 ·Status: WITHDRAWN ·Phase: NA
-
Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
NCT03075514 ·Status: COMPLETED ·Phase: NA
-
Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients
NCT03904628 ·Status: UNKNOWN ·Phase: PHASE1